| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |